Human Platelet Lysate Market Share, Industry Analysis [2031]

Report Description

Market Outlook:

The Global Human Platelet Lysate Market was estimated at USD 75.3 Million in 2022 and is anticipated to reach USD 344.0 Million by 2031, expanding at a CAGR of 20.9% during the forecast period.

Human Platelet Lysate (hPL) is a cell culture growth supplement that is derived from human platelets. Human Platelet Lysate comprises abundant human growth factors, including PDGF, bFGF, EGF, TGF-beta1, VEGF, and other cytokines and proteins, which yield efficient results when culturing several types of human cells, particularly, human MSC (Mesenchymal Stem Cells) regardless of their tissue source.

Get Free Sample Report

Human platelet lysate (hPL) is considered as a valid substitute to fetal bovine serum (FBS) in the expansion of mesenchymal stromal cells (MSC), and it is commonly produced, starting from intermediate side products of whole blood donations.

hPL is significantly enriched in chemokines, growth factors, adhesion, and immunologic molecules through freeze-thaw cycles. Regulatory agencies have approved cell treatment techniques that use hPL instead of FBS for cell multiplication, and its delivery to patients is regarded as safe.

Macro-economic Factors

Rising GDPs of Emerging Economies

A country’s GDP growth rate is a key factor that influences the demand for cell culture products. Emerging economies such as Brazil, Russia, India, and China (BRIC) and other countries in Latin America and Southeast Asia are key destinations for the healthcare industry. Over half the world’s population resides in India and China, which makes these two regions the leading consumers of various healthcare products. Countries with high GDP growth rate tends to have high healthcare expenditure, which increases the demand for cell culture products. Thus, rising GDPs of emerging economies play a crucial role in fueling the market.

R&D Activities

Research & development (R&D) plays a significant role in determining the growth and future advancements of a country or region. R&D activities are an approach to scientific innovation that ultimately make a meaningful difference in lives of people across the globe. A majority of the key players in the market invest some part of their total sales in R&D activities aiming to discover new therapies or innovate their product portfolio. R&D investments, in terms of new products & services, improve processes, and new ways to interact with customers can result in high profits and low costs. R&D plays an enormous role from drug discovery to final drug approval and marketing. Regulatory bodies act as checkpoints. R&D has a major impact on the overall market.

Market Dynamics

Market Driver- Rise in demand for Regenerative Medicines

Regenerative therapies offer an innovative solution to several medical issues that are difficult or impossible to treat in traditional ways. Doctors stimulate tissue regeneration and restore function where needed by using stem cells and other specialized treatments. Regenerative medicine has the ability to restore or replace cell, tissue, and organ functions affected by disease, injury, or aging. This eventually helps in managing or curing many conditions that are currently considered as chronic, untreatable, or terminal. Platelet lysates have potential roles in wound healing, treatment of ocular graft-versus-host disease, osteoarthritis, Parkinson’s disease, tendon regeneration, infertility, androgenetic alopecia, nerve repair, and regenerative tissue, such as bone regeneration, owing to the presence of a large number of growth factors. Thus, the rise in demand for human platelet lysate in regenerative medicine is expected to drive the market over the forecast period.

Market Restraint- High Cost Associated with Production & Dearth of Skilled Personnels

High price of hPL is attributed to several factors, such as the limited availability of human platelet donors, complex and costly manufacturing process, stringent regulatory requirements, and the high demand from the stem cell research and therapy sector. Price of hPL varies, depending on the source, quality, quantity, and grade of the product. According to some online sources, the price of hPL ranges from $168 to $500 per 100 mL1. Dearth of skilled personnel is a major factor that is hampering the market growth. The cell culture process requires qualified/skilled personnel to perform and implement new techniques.

Market Opportunity- Advancements in Biopharmaceutical Industry

The biopharmaceutical industry is expected to be one of the rapidly growing industries in the near future, owing to the increasing demand for drugs and treatment for various infectious and chronic diseases across the globe. The biopharmaceutical industry is focusing on developing and producing various therapeutic products by using mammalian cells, which are modified for suspension culture. Increasing demand for the treatment of cancer, diabetes, cardiovascular disease, immune diseases, and other health problems is boosting research activities in the biopharmaceutical industry. Most biopharmaceuticals are derived from proteins (found in nature) and recombinant proteins, which contain scientifically operated genes. Culture media is widely used in the biopharmaceutical industry for the production of vaccines, blood factors which are based on cell culture technique. This is expected to drive the market.

Market Key Developments

In May 2022, AffyXell, a company focused on developing cell and gene therapies based on mesenchymal stem cells, announced a partnership with GenScript ProBio to accelerate the development of stem cell therapies by expanding their strategic manufacturing partnership in December 2021, that covered AffyXell’s first drug development program to embrace additional future programs. The partnership comprises process development and manufacturing of viral vectors that are mandatory for the production of AffyXell’s future cell therapy products.

In May 2020, CiRA Foundation collaborated with Cell and Gene Therapy Catapult (CGT Catapult) to launch a new research project focused on induced pluripotent stem cell characterization.

In July 2020, Anergis collaborated with Virometix to start research in the use of synthetic virus-like particles for ultra-fast allergy immunotherapy.

Scope of the Report  

The report on the Global Human Platelet Lysate Market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Segmental Outlook

Based on type, the global human platelet lysate market is segmented into heparin based human platelet lysate, fibrin-depleted human platelet lysate, xeno-free human platelet lysate, and others. The heparin-based human platelet lysate segment is expected to hold a significant share of the market during the forecast period, as it is increasingly applied in pathogen reduction technologies.

Get Free Sample Report

Based on product, the global human platelet lysate market is segmented into standard and customized. The standard segment is expected to hold a significant share of the market, due to the increasing demand for research activities in several research and academic institutes.

Get Free Sample Report

Based on form, the global human platelet lysate market is segmented into liquid and lyophilized. The liquid segment is expected to hold a significant share of the market, as it excludes the further processing of the product and saves manufacturing time.

Get Free Sample Report

Based on source, the global human platelet lysate market is segmented into platelet donation and platelet recovery. The platelet donation segment is expected to hold a significant share of the market, due to the increasing number of platelet donors globally.

Get Free Sample Report

Based on application, the global human platelet lysate market is segmented into research and therapeutic. The research segment is expected to hold a significant share of the market, due to ongoing research studies for novel therapies.

Get Free Sample Report

Based on end users, the global human platelet lysate market is segmented into pharmaceutical and biotechnology companies, academic & research institutes, stem cell research centers, contract research organizations, hospitals, and cell bank facilities. The pharmaceutical & biotechnology companies segment is anticipated to grow at a rapid pace in the near future, as personalized medicine provides suitable therapeutic options for the treatment of patients.

Get Free Sample Report

Based on distribution channel, the global human platelet lysate market is segmented into online and offline. The offline segment is expected to hold a significant share of the market during the forecast period owing to the benefits of quick product return without delay, availability of a variety of products, and personalized recommendations from staff.

Get Free Sample Report

Regional Outlook

On the basis of regions, the Global Human Platelet Lysate Market is segmented into North America, Europe, APAC, Latin America, and the Middle East and Africa. Additionally, increasing stem cell research in North America and Europe is fueling the market in these regions.

North America and Europe held the market share of owing to the presence of a large number of biopharmaceutical companies and contract research organizations. Additionally, increasing stem cell research in North America and Europe is fueling the market in these regions.

The market in Asia Pacific is expected to expand at a rapid pace during the forecast period. Increasing medical treatments including platelet-rich plasma (PRP) therapies in this region is driving the market. Additionally, improving healthcare infrastructure is contributing to the growth of the market in Asia Pacific.

Get Free Sample Report

Key Benefits for Industry Participants & Stakeholders

• In-depth Analysis of the Global Human Platelet Lysate Market

• Historical, Current, and Projected Market Size in terms of Value

• Potential & Niche Segments and Regions Exhibiting Promising Growth Covered

• Industry Drivers, Restraints, and Opportunities Covered in the Study

• Recent Industry Trends and Developments

• Competitive Landscape & Strategies of Key Players

• Neutral Perspective on Global Human Platelet Lysate Market performance